Advertisement

Topics

Dainippon Pharmaceutical Company Limited Company Profile

05:24 EDT 23rd September 2017 | BioPortfolio

Antibiotics Diagnostics Veterinary

Location

6-8 Dosho-machi 2-chome Chuo-ku
Osaka
Osaka
541
Japan

Contact

Phone: 81 6 6203 5321
Fax: 81 6 203 6581


News Articles [1689 Associated News Articles listed on BioPortfolio]

Sumitomo Dainippon Pharma Co., Ltd. Strategy, SWOT and Corporate Finance Report [Report Updated: 02082017] Prices from USD $175

Sumitomo Dainippon Pharma Co., Ltd. Strategy, SWOT and Corporate Finance ReportSummarySumitomo Dainippon Pharma Co., Ltd. Strategy, SWOT and Corporate Finance Report, is a source of comprehensive co...

Sumitomo Dainippon seeks new indication for PD drug in Japan

Tokyo’s Sumitomo Dainippon Pharma has applied to extend its Japanese marketing authorization for Parkinson’s…

Sumitomo Dainippon Pharma Co., Ltd. Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 14062017] Prices from USD $350

Sumitomo Dainippon Pharma Co., Ltd. Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's Sumitomo Dainippon Pharma Co., Ltd. Mergers Acquisitions MA, Partnershi...

Maruishi gets rights to antiemetic in all-Japanese deal

Maruishi Pharmaceutical is to pay fellow Japanese drugmaker Sumitomo Dainippon Pharma for exclusive development,…

Tolero Pharmaceuticals Appoints Robert Imani Vice President, Drug Development

SALT LAKE CITY, May 8, 2017 /PRNewswire/ -- Tolero Pharmaceuticals, Inc., a clinical-stage company developing treatments for serious hematological diseases, today announced Robert Imani, M.D., Ph.D. h...

Takeda Pharmaceutical Company Limited Strategy, SWOT and Corporate Finance Report [Report Updated: 02082017] Prices from USD $175

Takeda Pharmaceutical Company Limited Strategy, SWOT and Corporate Finance ReportSummaryTakeda Pharmaceutical Company Limited Strategy, SWOT and Corporate Finance Report, is a source of comprehensiv...

M Pharmaceutical, Inc.: M Pharmaceutical Inc. Engages Camargo Pharmaceutical Services to Develop Regulatory Strategy for Recently Patented Extrinsa for the Treatment of Female Sexual Dysfunction

CINCINNATI, OH / ACCESSWIRE / June 2, 2017 / M Pharmaceutical Inc. (CSE: MQ, OTCQB: MPHMF, FWB: T3F2), (the "Company" or "M Pharma"), is pleased to announce that it has engaged Camargo Pharmaceutic...

Oasmia Pharmaceutical AB: Issuance of warrants in Oasmia Pharmaceutical AB (publ)

Oasmia Pharmaceutical AB (publ) (the "Company") resolved, at the Extraordinary General Meeting of the Company on 2 June 2017, to establish two warrant programmes, series 2017:1 and series 2017:2, i...

PubMed Articles [506 Associated PubMed Articles listed on BioPortfolio]

Pharmaceutical Marketing for Rare Diseases: Regulating Drug Company Promotion in an Era of Unprecedented Advertisement.

Critical review of surface-enhanced Raman spectroscopy applications in the pharmaceutical field.

Surface-enhanced Raman spectroscopy (SERS) is a sensitive analytical tool used in the pharmaceutical field in recent years. SERS keeps all the advantages of classical Raman spectroscopy while being is...

Sharing is Caring: The Case for Company-Level Collaboration in Pharmacoeconomic Modelling.

Adventures in the Environmental World and Environmental Microbiology Sampling of Air for Pharmaceutical Sterile Compounding.

Chapter issued by the United States Pharmacopeial Convention, Inc. is the standard for sterile compounding. It is designed to reduce the number of patient infections due to contaminated pharmaceutica...

Can pharmaceutical co-crystals provide an opportunity to modify the biological properties of drugs?

Poorly soluble and/or permeable molecules jeopardize the discovery and development of innovative medicines. Pharmaceutical co-crystals, formed by an active pharmaceutical substance (API) and a co-crys...

Clinical Trials [312 Associated Clinical Trials listed on BioPortfolio]

Epidemiology of Cardiovascular and Non-Cardiovascular Risk In Chicago

To continue the comprehensive research program on the epidemiology of cardiovascular and other major chronic diseases, including cancer and diabetes, in four Chicago population cohorts. T...

Pharmaceutical Care for Asthma Control Improvement (PHARMACI)-Study

The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for asthma patients.

Pharmaceutical Care for Diabetes Type 2 Patients: a Randomised Controlled Trial

The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for diabetes type 2 patients. Patients will be randomly allocated to th...

Pravastatin 80 mg Tablets Dosed in Healthy Subjects Under Non-Fasting Conditions

This study compared the relative bioavailability (rate and extent of absorption) of Pravastatin Sodium Tablets 80 mg by Teva Pharmaceutical Industries, Ltd. with that of Pravachol® Tablet...

Immunogenicity and Safety of Kinrix + MMR With and Without Varicella Vaccine in Healthy Children 4-6 Years

The purpose of the study is to evaluate the immunogenicity and safety of Kinrix when co-administered with varicella (Varivax® [varicella virus vaccine live], Merck and Company) and MMR va...

Companies [2883 Associated Companies listed on BioPortfolio]

Dainippon Sumitomo Pharma Co., Ltd.

Dainippon Sumitomo Pharma Co., Ltd., (DSP), is a top-ten listed pharmaceutical company in Japan with a diverse portfolio of pharmaceutical, animal health and food and specialty products. DSP's strong...

Dainippon Pharmaceutical Company Limited

Antibiotics Diagnostics Veterinary

Dainippon Sumitomo Pharma America, Inc.

Dainippon Sumitomo Pharma America, Inc. (DSPA) located in Fort Lee, N.J., is a subsidiary of Dainippon Sumitomo Pharma Co., Ltd. (DSP). On April 1, 2010, DSP's two North American operations - DSPA and...

Microsulis Medical Limited

Founded in 1997, Microsulis Medical Limited is a UK-based medical device company that exploits specialist intellectual property in medical microwave design to create therapeutic d...

Immunocore Limited

Immunocore Limited is developing innovative biological therapeutics to treat a range of cancers, chronic viral infections and diabetes. Immunocore is a privately owned biotechnology company located ...

More Information about "Dainippon Pharmaceutical Company Limited" on BioPortfolio

We have published hundreds of Dainippon Pharmaceutical Company Limited news stories on BioPortfolio along with dozens of Dainippon Pharmaceutical Company Limited Clinical Trials and PubMed Articles about Dainippon Pharmaceutical Company Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Dainippon Pharmaceutical Company Limited Companies in our database. You can also find out about relevant Dainippon Pharmaceutical Company Limited Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record